How can optoacoustic imaging benefit you?
iThera Medical’s MSOT inVision series is the only optoacoustic imaging system with real-time whole-body imaging capability for small animals. Multispectral optoacoustic tomography (MSOT) introduces a new standard for the exploration of biological processes and the kinetics of pharmacological substances.
At the same time, iThera Medical is the undisputed leader in translating OAI into the clinic. A significant number of clinical trials has been successfully completed using the MSOT Acuity, ranging from melanoma to breast cancer, from Crohn’s disease to systemic sclerosis.Learn more
iThera Medical is the only company offering OAI systems in the mesoscopic regime – achieving 2-3mm depth penetration at a resolution of down to 20µm.
Raster-scanning optoacoustic mesoscopy (RSOM) has so far been explored in a variety of tumor-associated preclinical studies, using the RSOM Explorer P50 to look at angiogenesis and changes in tumor vasculature under treatment. For clinical imaging, the RSOM Explorer C50 has been used for clinical trials in skin cancer and a wide range of skin diseases associated with inflammation.Learn more